{"nct_id":"NCT04623775","title":"A Study of Relatlimab Plus Nivolumab in Combination With Chemotherapy vs. Nivolumab in Combination With Chemotherapy as First Line Treatment for Participants With Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-02","start_date":"2021-02-17","start_date_type":"ACTUAL","primary_completion_date":"2024-01-11","primary_completion_date_type":"ACTUAL","completion_date":"2026-01-30","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["BMY"]}